171 related articles for article (PubMed ID: 15069314)
21. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
22. [A preliminary study on genome-wide expression profiling of laryngeal squamous cell carcinoma].
Wang R; Ma H; Lian M; Yang F; Wang H; Feng L; Fang J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 49(3):232-5. PubMed ID: 24820496
[TBL] [Abstract][Full Text] [Related]
23. Predicting miRNA targets for head and neck squamous cell carcinoma using an ensemble method.
Gao H; Jin H; Li G
Int J Biol Markers; 2018 Jan; 33(1):87-93. PubMed ID: 28665450
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
[TBL] [Abstract][Full Text] [Related]
25. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
26. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
27. Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature.
Cortesina G; Martone T
Acta Otorhinolaryngol Ital; 2006 Dec; 26(6):317-25. PubMed ID: 17633150
[TBL] [Abstract][Full Text] [Related]
28. Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.
Korosec B; Glavac D; Volavsek M; Ravnik-Glavac M
Cancer Genet Cytogenet; 2008 Mar; 181(2):112-8. PubMed ID: 18295663
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and Molecular Biology of Head and Neck Cancer.
Jou A; Hess J
Oncol Res Treat; 2017; 40(6):328-332. PubMed ID: 28531899
[TBL] [Abstract][Full Text] [Related]
30. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma.
Zou AE; Ku J; Honda TK; Yu V; Kuo SZ; Zheng H; Xuan Y; Saad MA; Hinton A; Brumund KT; Lin JH; Wang-Rodriguez J; Ongkeko WM
RNA; 2015 Jun; 21(6):1122-34. PubMed ID: 25904139
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review.
Patmore HS; Cawkwell L; Stafford ND; Greenman J
Ann Surg Oncol; 2005 Oct; 12(10):831-42. PubMed ID: 16132373
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance.
Smith BD; Haffty BG; Sasaki CT
Ann Otol Rhinol Laryngol; 2001 Mar; 110(3):221-8. PubMed ID: 11269765
[TBL] [Abstract][Full Text] [Related]
33. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
[TBL] [Abstract][Full Text] [Related]
35. Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.
Rose BR; Thompson CH; Tattersall MH; O'Brien CJ; Cossart YE
Aust N Z J Surg; 2000 Aug; 70(8):601-6. PubMed ID: 10945556
[TBL] [Abstract][Full Text] [Related]
36. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
37. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
38. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):3-13. PubMed ID: 27557665
[TBL] [Abstract][Full Text] [Related]
39. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
40. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]